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Can Patients With Active Duodenal
Ulcer Fast Ramadan?
TO THE EDITOR: During Ramadan (ninth month of Hijra
calendar), Muslims all over the world abstain from food and
drink from dawn to dusk. This change of eating pattern
during this month exerts effects on various physiological
parameters (1, 2), including gastric acid secretion or gastro-
intestinal motility (3, 4). Although Allah has made fasting
obligatory upon every Muslim, He has exempted those in
whom fasting or any other illness may aggravate their con-
ditions. Therefore, it is usual for Muslim patients, having
gastrointestinal disturbances, especially peptic ulcer, to ask
about the effects of fasting on their gastrointestinal condi-
tion. An epidemiological study has shown an increase in
digestive disturbance during the first week of Ramadan (5).
However, reports about the effects of Ramadan fasting on
active peptic ulcers of patients on medical treatment are
scant. A clinical study was, therefore, designed to assess the
effect of Ramadan fasting on the healing process of peptic
ulcer of patients on omeprazole (a proton pump inhibitor)
treatment.
Fifty patients were selected, by simple sampling, having
one or more of the following criteria, confirmed in endos-
copy:
1. Active duodenal ulcer;
2. Multiple superficial bulbar ulcers;
3. Pyloric channel ulcer;
4. Active gastric ulcer;
5. Erosive duodenitis;
6. Duodenal or gastric ulcer with active bleeding.
All patients received 20 mg of omeprazole b.i.d., except the
ones with a positive urease test who received amoxicillin
(1000 mg) and metronidazole (500 mg) (b.i.d., for 2 wk),
other than omeprazole. Patients were free to fast or break it.
Eighteen patients observed the fast, and 21 patients broke it.
Then, during 5 days, from the end of Ramadan, patients
were endoscopied again and the results compared with the
endoscopic findings of these patients at the beginning of the
study.
Thirty-nine patients with duodenal ulcer completed the
study. Among them, 18 patients observed the fast for 25–30
days, whereas 21 patients broke it. Two fast and two nonfast
patients were smokers. None of the patients consumed non-
steroidal anti-inflammatory drugs or alcohol during the
study. Statistically, there were no differences between the
ages or sexes in the two groups. Endoscopic findings doc-
umented a 94.4% (17 of 18) cure in the fast group and a
95.5% (20 of 21) cure in the nonfast group. In an endoscopic
picture of one patient in the fast group, multiple superficial
bulbar ulcers could be observed. He had observed the fast
for the first and second days of Ramadan, but had to break
it afterward because of severe epigastric pain. The cure was
not more than 10% at the end of the study. One patient in the
nonfast group was a 45-yr old smoker. In his endoscopic
picture, at the beginning of the study, an active duodenal
ulcer without deformity could be observed. Not more than
50% improvement could be observed despite taking his
drugs thoroughly. Other patients did not have any com-
plaints throughout the study and even 3 months later, on
follow-up.
The current study demonstrated that people could fast
even with having active doudenal ulcer if they took the drug
regimen employed in this study. Furthermore, fasting does
not have a deteriorating effect on healing of duodenal ulcer.
The results of this study are in contrast with the suggestion
of Feldman et al. (6) who claimed that patients who suffer
from acute duodenal or gastric ulcers should not fast, and
asymptomatic patients might try fasting, if they could take
a histamine-2 blocker at Iftar or Sahur (6). Our data are also
in contrast with the suggestion of Azizi (5) who claimed that
patients with active duodenal ulcers should not fast, even the
ones on treatment. It should be noted that the drug regimen
employed in this study is different from the one (cimethi-
dine) employed in the Azizi’s report (5).
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First Reported Case of Colitis Cystica
Profunda in Association With Crohn’s
Disease
TO THE EDITOR: Colitis cystica profunda (CCP) is an
uncommon condition characterized by benign, mucus-filled
cystic lesions within the submucosa. Histologically, it can
mimic invasive adenocarcinoma.
A 37-yr-old white man was admitted to our hospital with
a 1-day history of bloody diarrhea, crampy lower abdominal
pain, nausea, and bilious emesis. Past medical history was
significant for multiple sclerosis, which was currently in
remission. He denied taking any prescription or over-the-
counter medications. There was no family history of any
colorectal diseases.
Physical examination revealed a well-developed man in
moderate distress caused by abdominal pain. His vital signs
were: temperature 40°C, pulse 132/min, blood pressure
118/70 mm Hg, respiratory rate 18/min. The abdomen was
distended and diffusely tender to palpation. Bowel sounds
were hyperactive. Peritoneal signs were absent. Digital rec-
tal examination disclosed a scant amount of blood-tinged
stool. The rest of the physical examination was unremark-
able.
Blood counts showed Hb of 16.5 g/dL and a white blood
cell count of 21 k with 28% bands. Serum electrolytes, liver
and pancreatic enzymes, urinalysis, as well as stool studies
were unremarkable. An abdominal CT scan revealed diffuse
colonic wall thickening. A flexible sigmoidoscopy showed
mild diverticulosis, apthous ulcers, and severe edema, which
prevented advancement of the endoscope beyond 25 cm
from anal verge.
Colonic biopsies showed intact crypt architecture without
neutrophilic infiltrates, cryptitis, or crypt abscesses. Treat-
ment with i.v. ciprofloxacin and metronidazole did not result
in improvement. Repeat sigmoidoscopy performed 1 wk
later showed similar endoscopic and biopsy findings. The
patient was then started on corticosteroids for possible in-
flammatory bowel disease.
On hospital day 15, his symptoms worsened. A CT scan
of the abdomen showed colonic obstruction. Urgent surgery
demonstrated a sigmoid stricture with fat creeping of serosa.
Sigmoidectomy and end colostomy were performed. Gross
pathology of the resected colon revealed surface adhesions
and a lumen diameter of 0.7–1 cm. In the area of the
stricture, a 1.5–cm sac-like space was identified adjacent to
the bowel wall, which was filled with mucoid-appearing
material. Histologically, there were multiple cystic-appear-
ing lesions in the muscularis propria filled with acellular
mucin (Fig. 1).
Subsequent colonoscopy through colostomy revealed ex-
tensive patchy ulceration of the distal transverse and de-
scending colon. Biopsies demonstrated focal clusters of
multinucleated histiocytic giant cells, crypt distortion, and
active mucosal inflammation with increased mononuclear
cells and neutrophils in the lamina propria along with mu-
cosal ulceration consistent with Crohn’s disease. Treatment
with infliximab resulted in prompt remission.
CCP is an uncommon condition, which has been reported
in association with solitary rectal ulcer syndrome, rectal
prolapse, adenomatous polyps, radiation enteritis, and ul-
cerative colitis. Most people believe that it is postinflam-
matory or post-traumatic in origin (1). However, the rarity
of this condition suggests that some unknown mechanism
may play an additional role in pathogenesis. It typically
presents with passage of blood and mucus in stools but can
also present as diarrhea and abdominal pain. Barium enema
studies demonstrate filling defects or thickened mucosal
folds, which are often interpreted as mass lesion (2). Endo-
scopically, CCP appears as thickened edematous bowel wall
or sessile polypoidal mucosal lesions. Endoscopic ultra-
sound shows the presence of large submucosal cystic le-
sions.
Although CCP has not been described in association with
Crohn’s disease, there have been few case reports of “En-
Figure 1. CCP: Submucosal mucus-filled cystic lesion.
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